Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Rubicon Genomics; RayBiotech

NEW YORK (GenomeWeb News) – Rubicon Genomics said this week that its 2013 revenues increased 85 percent year over year on sales of its nucleic acid library preparation products, ThruPlex-FD Prep Kits and PicoPlex WGA Kits. ThruPlex-FD Prep Kits for Illumina’s next-generation sequencing platforms provides sequencing from challenging samples with very small amounts of DNA or degraded DNA, Rubicon said. PicoPlex-WGA Kits amplify DNA to yield a highly reproducible library from single cells with input concentrations as low as 15 picograms.


RayBiotech announced the 22 winners of its 2013 Innovative Research Grants. The grants program targets a wide range of basic and applied research topics in the life sciences, including models systems for biological processes and disease. The winners were chose from more than 120 grant applicants. RayBiotech is awarding $5,000 to $20,000 worth of protein array and immunoassay-based products and services to each grant winner. A list of the winners can be found here.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.